Pfizer

Last week, Pfizer and BioNTech filed for emergency authorization of their coronavirus vaccine with the Food and Drug Administration.

Pharmaceutical manufacturer Pfizer began shipping doses of its COVID-19 vaccine Friday via chartered cargo flights between Brussels, Belgium, and Chicago to have stockpiles in position for distribution as soon as it is approved for inoculations by regulators, The Wall...

Don't let the COVID crisis put a damper on your Thanksgiving Day.  Several years ago the founder of the Association of Mature American Citiz

Companies are implementing their own plans to rapidly distribute coronavirus vaccines. "United Airlines Holdings Inc. on Friday began operating charter flights to position doses of Pfizer Inc.'s Covid-19 vaccine for quick distribution if the shots are approved by regulators," The Wall Street Journal reported Friday, citing "people familiar with the matter." "The initial flights are […]

Wall Street stocks advanced, with the Nasdaq closing at a record high, on Friday in a holiday-shortened week as retailers kicked off the year-end shopping season amid record COVID-19 hospitalizatio…

Gold prices have been in the red for the third consecutive week. U.S. stocks and emerging markets' currencies have been attracting investors.

Brazilian President Jair Bolsonaro says he won't take any working COVID-19 vaccine himself…

SCI COMMUN### Infectious diseases The 11th Ebola outbreak in the Democratic Republic of the Congo (DRC) is officially over, giving the country respite from the disease for the first time in more than 2 years. On 18 November, the World Health Organization (WHO) announced that no new cases had been identified for 42 days, twice the incubation period for the deadly virus. The outbreak, in the western Équateur…

We know the top vaccines can prevent people from getting sick with COVID-19, but we don't know if they prevent people from spreading the virus.

Seven California hospitals will be among the first to receive vaccines.

Crude oil prices are trading at the highest levels since March on positive news related to Covid-19 vaccine and diminishing concerns over weak demand next year. Fundamental analysis: Improving risk sentiment  Crude oil prices gained on the announcements from three major drugmakers including Pfizer-BioNTech, Moderna and Oxford that the coronavirus vaccine rollouts could begin in December.  "Despite a number of…

Pandemic puts AIDS-related gains at risk, Museum of London asks citizens to share Covid dreams, virus revives debate on value of high-stake exams, and other pandemic-related news across the globe

Scientists urge the Oxford University team to begin a new large-scale trial to prove the "serendipitous observation."

The comments come ahead of a Dec. 10 meeting where FDA regulators will review Pfizer and BioNTech's request for an emergency use authorization for their COVID-19 vaccine.

AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study

LONDON (AP) — The British government said Friday it has formally asked the country's medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be

AstraZeneca and Oxford University acknowledged a manufacturing error that raised questions about preliminary results of their experimental COVID-19 vaccine.

AstraZeneca Plc. is likely to conduct an additional global trial to assess the efficacy of its covid-19 vaccine, according to the company's chief executive officer, after current studies raised questions over its level of protection. The new trial would be run instead of adding an arm to an ongoing U.S.

AstraZeneca said Monday that its vaccine was found to be up to 90% effective at preventing COVID-19. But an error in that trial may warrant a new one.

Long before Moderna and Pfizer's COVID-19 shots, scientists had been considering the use of genetically encoded vaccines in the fight against infectious diseases, cancer, and more.